Skip to content

14 Weeks Exercise Training on Lean Women With and Without PCOS

14 Weeks Exercise Training on Lean Women With and Without PCOS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02429128
Enrollment
22
Registered
2015-04-29
Start date
2014-07-31
Completion date
2016-07-31
Last updated
2016-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome (PCOS)

Keywords

Polycystic Ovary Syndrome (PCOS)

Brief summary

The aim of this project is to investigate the pathophysiology of PCOS in regards to the metabolic profile including defects in insulin sensitivity in skeletal muscle and adipose tissue, and to investigate the effects of exercise training on these parameters.

Interventions

OTHER14 weeks exercise training

Sponsors

University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

Women with PCOS * Hyperandrogenism and/or hyperandrogenemia * Regular menstruation * Age: 20-40 * Inactive or low physical activity level * Low to moderate fitness status Inclusion Criteria: Women without PCOS * Normal levels of plasma androgens * Polycystic ovary and/or menstrual dysfunction * Age: 20-40 * Inactive or low physical activity level * Low to moderate fitness status

Exclusion criteria

Women with and without PCOS * Pregnancy or breast feeding * Smoking * Use of birth control pills 3 mo before enrolment

Design outcomes

Primary

MeasureTime frameDescription
Compliance to exercise training program as assessed by number of training sessions completed14 weeksSuperviced training program - no. of training sessions are noted by trainer. Compliance must be higher than 80%.
No change in Body Weight14 weeks
Component of metabolic syndrome14 weeksHole body insulin sensitivity measured by HOMA index

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026